Techno Medica Co., Ltd.
6678.T
Get informed when a big investor buys or sells
+ FollowMarket Cap$13.31B
Close$
$5181.83
159.5% upside
Current Fair Value
159.5% upsideUndervalued by 159.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $13.31 Billion |
|---|---|
| Enterprise Value | $4.75 Billion |
| Dividend Yield | $129.00 (6.46%) |
| Earnings per Share | $155.28 |
| Beta | 0.26 |
| Outstanding Shares | 6,662,906 |
Return
| Return on Equity | 8.85% |
|---|---|
| Return on Assets | 7.47% |
| Return on Invested Capital | 13.63% |
Valuation & Multiples
| P/E Ratio | 11.3 |
|---|---|
| PEG | 1.31 |
| Price to Sales | 1.14 |
| Price to Book Ratio | 0.97 |
| Enterprise Value to Revenue | 0.41 |
| Enterprise Value to EBIT | 2.49 |
| Enterprise Value to Net Income | 3 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 6, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Techno Medica Co., Ltd.
239 employees
CEO: Masatomo Saneyoshi Techno Medica Co., Ltd. is a Japanese company that specializes in the entire lifecycle of in-vitro diagnostic analyzers, covering their research, development, manufacturing, distribution, and international trade. Their product portfolio ...